FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient

Yeongjoo Lee; Hye Sung Won; Kyung Jin Seo; Sae Jung Na

doi:10.1097/RLU.0000000000005515

FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient

Yeongjoo Lee, Hye Sung Won, Kyung Jin Seo, Sae Jung Na

Division of Nuclear Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

A 60-year-old man diagnosed with gastric adenocarcinoma underwent FDG PET/CT. After completing 9 cycles of combination chemotherapy with nivolumab and FOLFOX, he had multiple new nodular uptakes in the bilateral cervical chains and mediastinum. The pathology of the right neck node confirmed reactive lymph node hyperplasia without evidence of malignancy, suggesting pseudoprogression after immunotherapy. It is worthwhile to report these PET image patterns, as they could significantly influence clinical decision-making.

Original language	English
Pages (from-to)	1139-1141
Number of pages	3
Journal	Clinical Nuclear Medicine
Volume	49
Issue number	12
DOIs	https://doi.org/10.1097/RLU.0000000000005515
State	Published - 1 Dec 2024

Bibliographical note

Publisher Copyright:
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Keywords

FDG PET/CT
nivolumab
pseudoprogression

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/RLU.0000000000005515

Cite this

@article{fa15ae3ec46d456aad899ead42e2c7c5,

title = "FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient",

abstract = "A 60-year-old man diagnosed with gastric adenocarcinoma underwent FDG PET/CT. After completing 9 cycles of combination chemotherapy with nivolumab and FOLFOX, he had multiple new nodular uptakes in the bilateral cervical chains and mediastinum. The pathology of the right neck node confirmed reactive lymph node hyperplasia without evidence of malignancy, suggesting pseudoprogression after immunotherapy. It is worthwhile to report these PET image patterns, as they could significantly influence clinical decision-making.",

keywords = "FDG PET/CT, nivolumab, pseudoprogression",

author = "Yeongjoo Lee and Won, {Hye Sung} and Seo, {Kyung Jin} and Na, {Sae Jung}",

year = "2024",

month = dec,

day = "1",

doi = "10.1097/RLU.0000000000005515",

language = "English",

volume = "49",

pages = "1139--1141",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "12",

}

TY - JOUR

T1 - FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient

AU - Lee, Yeongjoo

AU - Won, Hye Sung

AU - Seo, Kyung Jin

AU - Na, Sae Jung

PY - 2024/12/1

Y1 - 2024/12/1

N2 - A 60-year-old man diagnosed with gastric adenocarcinoma underwent FDG PET/CT. After completing 9 cycles of combination chemotherapy with nivolumab and FOLFOX, he had multiple new nodular uptakes in the bilateral cervical chains and mediastinum. The pathology of the right neck node confirmed reactive lymph node hyperplasia without evidence of malignancy, suggesting pseudoprogression after immunotherapy. It is worthwhile to report these PET image patterns, as they could significantly influence clinical decision-making.

AB - A 60-year-old man diagnosed with gastric adenocarcinoma underwent FDG PET/CT. After completing 9 cycles of combination chemotherapy with nivolumab and FOLFOX, he had multiple new nodular uptakes in the bilateral cervical chains and mediastinum. The pathology of the right neck node confirmed reactive lymph node hyperplasia without evidence of malignancy, suggesting pseudoprogression after immunotherapy. It is worthwhile to report these PET image patterns, as they could significantly influence clinical decision-making.

KW - FDG PET/CT

KW - nivolumab

KW - pseudoprogression

UR - http://www.scopus.com/inward/record.url?scp=85208291872&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000005515

DO - 10.1097/RLU.0000000000005515

M3 - Article

C2 - 39485872

AN - SCOPUS:85208291872

SN - 0363-9762

VL - 49

SP - 1139

EP - 1141

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 12

ER -

FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this